Sign In
Last checked at 
10 Jun 2021 11:32
10 June 2021
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
AstraZeneca PLC
Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 26 May 2021, Morgan Stanley & Co. International plc as Coordinating Stabilisation Manager (contact: Morgan Stanley Debt Syndicate - Daniel Shane; telephone:+44 20 7677-7070) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014),as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.
Issuer: | AstraZeneca PLC |
Guarantor (if any): | N/A |
ISIN: | XS2347663507 |
Aggregate nominal amount: | EUR 800,000,000 |
Description: | EUR 800,000,000 0.375 per cent. Notes due 2029 |
Stabilisation Manager(s): | Morgan Stanley & Co. International plc Goldman Sachs International J.P. Morgan Securities plc |
Offer price: | 99.584% |
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.
Follow the stocks
